Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.87B | 8.58B | 7.24B | 5.52B | 6.09B |
Gross Profit | 2.01B | 1.83B | 1.33B | 774.00M | 434.00M |
EBITDA | 1.26B | 1.00B | 617.00M | 153.00M | -2.34B |
Net Income | 635.00M | 993.00M | 155.00M | -245.00M | -2.54B |
Balance Sheet | |||||
Total Assets | 11.36B | 11.29B | 10.13B | 9.55B | 9.93B |
Cash, Cash Equivalents and Short-Term Investments | 1.23B | 816.00M | 1.07B | 1.59B | 1.69B |
Total Debt | 2.39B | 2.38B | 2.37B | 2.39B | 2.56B |
Total Liabilities | 4.93B | 5.05B | 5.00B | 4.49B | 4.65B |
Stockholders Equity | 6.38B | 6.17B | 5.13B | 5.06B | 5.28B |
Cash Flow | |||||
Free Cash Flow | 953.00M | -140.00M | -393.00M | 90.00M | 700.00M |
Operating Cash Flow | 1.30B | 143.00M | -179.00M | 291.00M | 926.00M |
Investing Cash Flow | -471.00M | -293.00M | -238.00M | -196.00M | -144.00M |
Financing Cash Flow | -406.00M | -103.00M | -96.00M | -189.00M | -259.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $14.98B | 17.26 | 29.27% | 0.55% | 12.15% | 91.88% | |
76 Outperform | $19.30B | 10.50 | 18.16% | 3.03% | -4.08% | -29.26% | |
75 Outperform | $45.40B | 15.07 | 18.32% | 1.91% | 2.13% | 54.69% | |
74 Outperform | $53.24B | 12.15 | 19.78% | 3.16% | 0.94% | -4.63% | |
74 Outperform | $5.25B | 9.32 | 9.29% | 3.65% | 0.54% | -39.88% | |
67 Neutral | $15.15B | 9.89 | 6.22% | 5.21% | 4.47% | -70.67% | |
66 Neutral | $4.94B | 17.04 | 16.16% | 1.84% | -4.17% | -17.99% |
On May 20, 2025, NOV Inc. held its Annual Meeting of Stockholders where key decisions were made, including the re-election of nine board members, the ratification of Ernst & Young LLP as auditors for 2025, approval of executive compensation, and amendments to the Long-Term Incentive Plan. Additionally, the Board declared a supplemental dividend of $0.21 per share and a regular quarterly dividend of $0.075 per share, reflecting the company’s commitment to returning capital to shareholders.
The most recent analyst rating on (NOV) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on NOV stock, see the NOV Stock Forecast page.